Yong Chang

Yong Chang has a strong work experience in the biotechnology and healthcare industries. Yong started their career at Bayer HealthCare in 2001 as a Sr. Scientist before moving on to MedImmune, Inc. in 2006 where they served as the Head of Translational Pharmacology. In 2011, they joined Aileron Therapeutics as the Sr. Director, Head of Biology and later became the Vice President, Biology and Translational Research in 2013. Currently, they hold the position of Vice President, R&D at Intellia Therapeutics, Inc. since 2015.

Yong Chang attended Penn State University from 1993 to 1998. No information was provided on the degree or field of study pursued.